Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-21-004815
Filing Date
2021-10-08
Accepted
2021-10-08 17:26:36
Documents
2
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form3-10082021_021028.html 3  
1 form3-10082021_021028.xml 3 2973
2 ex24-10082021_021029.htm EX-24 6677
  Complete submission text file 0001415889-21-004815.txt   11089
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

EIN.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address
Laccona Nicholas (Reporting) CIK: 0001886497 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36845 | Film No.: 211316155